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Introduction
In the UK, VV ECMO is only commissioned [1] for speci-
fic patients - the list of perceived contra-indications is
long which prevents some patients having access to this
rescue technique. Recognising this, the National Peer
Review Programme stated that there may be cases “who
might benefit from ECMO support who also require super-
specialist services” - these may lack equity of access to
commissioned resources.
Objectives
To examine the outcomes of moribund patients, with
complex multi-system disease, who fall outside of the
present commissioning for VV ECMO, or who are
unsuitable for transfer due to specialist tertiary needs.
Methods
All ECLS patients since service inception in late 2012
had data prospectively collated on their severity of
illness.
For our VA group we have recently reported an ELSO
SMR (eSMR) for quality assurance. For those who were
unsuitable for, or refused transfer to, commissioned VV
centres, and in whom we initiated VV ECMO, we ana-
lysed outcomes and organ failure.
Results
There were 49 ECLS runs in 45 patients, & 24 runs
within the last year. For VA cases including all eCPR,
survival to discharge was 48% (eSMR 0.76). There were
17 VV runs in 16 patients. All were moribund by critical
care standards, aged 11 - 52, median 29.5. They included
6 with acute liver failure, 7 in receipt of liver transplant,
4 with complex trauma, 1 tracheal obstruction, 1 post-
partum cystic fibrosis & 1 post BMT. One was eCPR,
8 were peri-arrest or had already had a recent cardiac
arrest. 100 % met the inclusion criteria for VV ECMO,
but 56% were receiving a strict neuro-protective regime
for TBI, ICH, post cardiac arrest or cerebral oedema,
75% had severe circulatory failure (50% on > 1 mcg/kg/
min noradrenaline), 69 % were on CRRT, 44% had liver
failure, 100% had a significant risk of bleeding - mean
lactate was 7.65 with 44% having a lactate > 10. Overall,
62.5% had weaned and 50% had survived at the time of
this report. They should have both recognition and
equity of access to NHS (England) resource. There is
nowhere else to turn.
Conclusions
1. King’s College Hospital meets the caseload criteria,
ELSO guidelines and quality assurance data for a centre
undertaking all modes of ECLS.
2. In a young moribund group of patients who were
unsuitable for VV ECMO in the national centres, our VV
ECMO cohort did excellently with 50% surviving even
though such patients would normally be denied this criti-
cal care rescue technique - particularly in the UK.
3. NHSE should work with hospitals outside of the
commissioned centres to ensure equity of access and
effective outcomes for patients with complex multi-sys-
tem disease.
4. ECMO should form part of the armamentarium of
tertiary critical care services, especially for super-specia-
list populations that are not represented in the commis-
sioned centres - and there are disadvantages - in terms
of equity of access - to overly restricting this service.
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